OptimizeRx Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
OptimizeRx Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • OptimizeRx Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$9.12M, a 218% decline year-over-year.
  • OptimizeRx Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$24.2M, a 75.8% decline year-over-year.
  • OptimizeRx Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$17.6M, a 53.6% decline from 2022.
  • OptimizeRx Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$11.4M, a 3125% decline from 2021.
  • OptimizeRx Corp annual Net Income (Loss) Attributable to Parent for 2021 was $378K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$24.2M -$9.12M -$6.26M -218% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$17.9M -$4.01M +$153K +3.68% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$18.1M -$6.9M -$502K -7.85% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$17.6M -$4.14M -$3.82M -1171% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 -$13.7M -$2.87M +$602K +17.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$14.4M -$4.16M -$276K -7.11% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$14.1M -$6.4M -$2.64M -70.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$11.4M -$326K -$949K -152% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$10.5M -$3.47M -$3.51M -8790% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$6.98M -$3.88M -$4.24M -1203% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$2.75M -$3.76M -$3.12M -490% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 $378K $623K -$734K -54.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $1.11M $39.9K +$323K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $789K $352K +$1.43M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$641K -$637K +$1.57M +71.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$2.21M $1.36M +$3.34M Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
Q3 2020 -$5.55M -$283K +$1.29M +82% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$6.84M -$1.08M -$1.48M -365% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$5.35M -$2.2M -$2.21M -33856% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.14M -$1.98M -$1.87M -1706% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$1.27M -$1.57M -$1.82M -741% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $548K $407K +$126K +45% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 $422K $6.53K +$196K Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 $226K -$110K +$127K +53.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $99.2K $245K +$868K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$769K $281K +$642K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.41M -$189K +$694K +78.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$2.1M -$237K +$116K +32.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$2.22M -$623K -$380K -157% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$1.84M -$362K +$230K +38.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$2.07M -$883K -$531K -151% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 -$1.54M -$353K +$61.9K +14.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$1.6M -$243K -$331K -376% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$1.27M -$592K -$435K -276% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$836K -$352K -$241K -216% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$595K -$415K -$645K -280% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 $50.2K $87.9K +$382K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$332K -$157K +$42.2K +21.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$374K -$111K +$651K +85.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$1.03M $231K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$295K +$117K +28.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$199K Apr 1, 2014 Jun 30, 2014 10-K/A 2015-09-16
Q1 2014 -$762K -$538K -240% Jan 1, 2014 Mar 31, 2014 10-K/A 2015-09-16
Q3 2013 -$412K Jul 1, 2013 Sep 30, 2013 10-K/A 2015-09-16
Q1 2013 -$224K +$76.3K +25.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q1 2012 -$301K +$79.2K +20.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q2 2011 -$433K +$442K +50.5% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-17
Q1 2011 -$380K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q2 2010 -$875K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.